Comparison of the Efficacy of Generation 1 and 2 Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Patients with EGFR Positive Mutations. Indian Journal of Forensic Medicine & Toxicology. 2021;15(3):4316-4324. doi:10.37506/ijfmt.v15i3.15970